Skip Navigation


Cardiovascular Research Advance Access first published online on April 29, 2008
This version [Corrected Proof] published online on May 17, 2008

Cardiovascular Research, doi:10.1093/cvr/cvn112
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
79/3/509    most recent
cvn112v2
cvn112v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wang, H.-H.
Right arrow Articles by Yeh, H.-I
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.-H.
Right arrow Articles by Yeh, H.-I
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Activation of endothelial cells to pathological status by down-regulation of connexin43

Hsueh-Hsiao Wang1, Chang-I Kung1, Yuen-Yi Tseng1, Yi-Chun Lin1, Chi-Hau Chen1, Cheng-Ho Tsai2,3,4 and Hung-I Yeh2,3,4,*

1 Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
2 Department of Internal Medicine, Mackay Memorial Hospital, 92, Sector 2, Chung San North Road, Taipei 10449, Taiwan
3 Mackay Medicine, Nursing and Management College, Taipei, Taiwan
4 Taipei Medical University, Taipei, Taiwan

* Corresponding author. Tel: +886 2 25433535 (ext. 2456); fax: +886 2 25433642. E-mail address: hiyeh{at}ms1.mmh.org.tw

Aims: We investigated the effects of connexin43 (Cx43) down-regulation on endothelial function.

Methods and results: We used two different sequences of Cx43-specific small interference RNA (siRNA) to reduce de novo synthesis of Cx43 in human aortic endothelial cells and then examined the expression profiles, proliferation activity and viability, and angiogenic potential. The involvement of mitogen-activated protein kinase signalling pathways was analysed. In parallel, the effect of inhibition of gap-junctional communication by connexin-mimetic peptides was evaluated. During the down-regulation of Cx43 by the siRNA, the cells exhibited impaired gap-junctional communication, proliferation, viability, and angiogenic potential. In addition, plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor were up-regulated. Furthermore, c-jun N-terminal kinase (JNK) and its downstream target c-jun were activated, while caspase-3, p38, and extracellular signal-regulated kinase remained unchanged. Inhibition of JNK by SP600125 blocked the siRNA-induced increased expression of PAI-1 and partially recovered the impaired angiogenic potential. Short-term inhibition of Cx43 channels by connexin-mimetic peptides did not activate JNK.

Conclusion: Down-regulation of Cx43 inhibits gap-junctional communication and activates endothelial cells to pathological status, as characterized by up-regulation of coagulatory molecules and impairment of proliferation, viability, and angiogenesis. The processes are associated with activation of JNK signalling pathways and rectified by inhibition of the activation. These results suggest that inadequate expression of Cx43 per se impairs endothelial function by the activation of stress-activated protein kinase.

KEYWORDS Angiogenesis; Connexins; Coagulatory factors; Gap junctions; c-jun N-terminal kinase


Time for primary review: 23 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.